BridgeBio Pharma (NasdaqGS:BBIO) FY Conference Transcript
2025-12-02 16:32BridgeBio Pharma (NasdaqGS:BBIO) FY Conference December 02, 2025 10:30 AM ET Company ParticipantsChinmay Shukla - VP of Strategic FinanceModeratorAll right. If we could get started, I'd like to welcome everyone to the Piper Sandler Healthcare Conference. With us is our next company. We have BridgeBio and Justin To, who is head of their Infigratinib, Skeletal Dysplasia program, and Chinmay Shukla, VP of Strategic Finance. Welcome, gentlemen. I guess, you know, first of all, congrats. I think, you know, if I ...